Free Trial

ImmuCell (ICCC) Short Interest Ratio & Short Volume

ImmuCell logo
$5.42 -0.03 (-0.55%)
As of 04/30/2025 04:00 PM Eastern

ImmuCell Short Interest Data

ImmuCell (ICCC) has a short interest of 4,500 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a -65.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 21,376 shares to cover all short positions.

Current Short Interest
4,500 shares
Previous Short Interest
13,200 shares
Change Vs. Previous Month
-65.91%
Dollar Volume Sold Short
$24,255.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
8,983,000 shares
Float Size
5,790,000 shares
Short Percent of Float
0.08%
Today's Trading Volume
3,157 shares
Average Trading Volume
21,376 shares
Today's Volume Vs. Average
15%
Short Selling ImmuCell?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ICCC Short Interest Over Time

ICCC Days to Cover Over Time

ICCC Percentage of Float Shorted Over Time

ImmuCell Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20254,500 shares $24,255.00 -65.9%0.1%0.3 $5.39
3/31/202513,200 shares $63,228.00 No Change0.2%1.3 $4.79
3/15/202513,200 shares $65,868.00 -22.8%0.2%1.7 $4.99
2/28/202517,100 shares $90,288.00 -6.6%0.3%1.7 $5.28
2/15/202518,300 shares $92,415.00 +18.1%0.3%1.5 $5.05
1/31/202515,500 shares $83,545.00 -1.9%0.3%1.2 $5.39
1/15/202515,800 shares $83,582.00 -3.7%0.3%1 $5.29
12/31/202416,400 shares $84,460.00 +24.2%0.3%0.9 $5.15
12/15/202413,200 shares $64,944.00 -14.8%0.2%0.7 $4.92
11/30/202415,500 shares $63,860.00 -34.3%0.3%0.7 $4.12
11/15/202423,600 shares $85,196.00 +490.0%0.4%0.7 $3.61
10/31/20244,000 shares $14,440.00 -51.2%0.1%0.1 $3.61
10/15/20248,200 shares $29,110.00 -29.9%0.2%0.2 $3.55
9/30/202411,700 shares $42,471.00 +37.7%0.3%0.3 $3.63
9/15/20248,500 shares $30,855.00 -54.3%0.2%0.2 $3.63
8/31/202418,600 shares $69,564.00 +644.0%0.4%0.6 $3.74
8/15/20242,500 shares $9,225.00 -40.5%0.0%0.1 $3.69
7/31/20244,200 shares $17,052.00 +5.0%0.1%0.4 $4.06
7/15/20244,000 shares $16,960.00 -29.8%0.1%0.4 $4.24
6/30/20245,700 shares $27,645.00 -12.3%0.1%0.5 $4.85
6/15/20246,500 shares $27,170.00 +30.0%0.1%0.5 $4.18
5/31/20245,000 shares $21,250.00 +66.7%0.1%0.4 $4.25
5/15/20243,000 shares $14,640.00 -41.2%0.1%0.3 $4.88
4/30/20245,100 shares $25,041.00 +13.3%0.1%0.6 $4.91
4/15/20244,500 shares $22,725.00 -26.2%0.1%0.6 $5.05
3/31/20246,100 shares $32,330.00 -4.7%0.1%0.8 $5.30
3/15/20246,400 shares $33,600.00 +1.6%0.1%0.8 $5.25
2/29/20246,300 shares $33,075.00 -20.3%0.1%0.8 $5.25
2/15/20247,900 shares $39,697.50 +5.3%0.1%0.9 $5.03
1/31/20247,500 shares $39,825.00 -2.6%0.1%0.8 $5.31
1/15/20247,700 shares $39,347.00 -13.5%0.1%0.6 $5.11
12/31/20238,900 shares $45,301.00 +30.9%0.2%0.8 $5.09
12/15/20236,800 shares $31,144.00 +13.3%0.1%0.5 $4.58
11/30/20236,000 shares $27,240.00 -7.7%0.1%0.4 $4.54
11/15/20236,500 shares $32,825.00 -52.2%0.1%0.4 $5.05
10/31/202313,600 shares $68,680.00 +70.0%0.3%0.8 $5.05
10/15/20238,000 shares $40,160.00 -28.6%0.1%0.5 $5.02
9/30/202311,200 shares $59,806.88 +62.3%0.2%0.7 $5.34
9/15/20236,900 shares $36,984.00 +15.0%0.1%0.4 $5.36
8/31/20236,000 shares $27,660.00 No Change0.1%0.4 $4.61
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
8/15/20236,000 shares $29,700.00 -11.8%0.1%0.5 $4.95
7/31/20236,800 shares $36,924.00 +11.5%0.1%0.6 $5.43
7/15/20236,100 shares $31,049.00 -3.2%0.1%0.6 $5.09
6/30/20236,300 shares $31,500.00 No Change0.1%0.7 $5.00
6/15/20236,300 shares $34,713.00 -6.0%0.1%0.8 $5.51
5/31/20236,700 shares $31,959.00 -30.2%0.1%0.8 $4.77
5/15/20239,600 shares $47,712.00 No Change0.2%1.1 $4.97
10/31/202210,500 shares $84,105.00 -38.2%0.2%1.3 $8.01
10/15/202217,000 shares $133,620.00 +60.4%0.3%2 $7.86
9/30/202210,600 shares $79,288.00 +6.0%0.2%1.2 $7.48
9/15/202210,000 shares $75,700.00 +19.1%0.2%1.1 $7.57
8/31/20228,400 shares $61,236.00 +12.0%0.2%0.9 $7.29
8/15/20227,500 shares $60,450.00 -24.2%0.1%1 $8.06
7/31/20229,900 shares $86,922.00 +32.0%0.2%1.1 $8.78
7/15/20227,500 shares $63,000.00 -13.8%0.1%0.7 $8.40
6/30/20228,700 shares $75,603.00 +24.3%0.2%0.8 $8.69
6/15/20227,000 shares $56,840.00 +1.5%0.1%0.6 $8.12
5/31/20226,900 shares $55,959.00 No Change0.1%0.6 $8.11
5/15/20226,900 shares $55,959.00 -45.2%0.1%0.6 $8.11
4/30/202212,600 shares $122,724.00 +41.6%0.2%1.1 $9.74
4/15/20228,900 shares $79,655.00 -22.6%0.2%0.8 $8.95
3/31/202211,500 shares $110,975.00 +21.1%N/A1.1 $9.65
3/15/20229,500 shares $82,270.00 +50.8%0.2%0.9 $8.66
2/28/20226,300 shares $51,471.00 -24.1%0.1%0.6 $8.17
2/15/20228,300 shares $68,226.00 +38.3%0.2%0.7 $8.22
1/31/20226,000 shares $48,900.00 -31.0%0.1%0.5 $8.15
1/15/20228,700 shares $76,617.42 +11.5%N/A0 $8.81
12/31/20217,800 shares $62,400.00 +39.3%0.1%1 $8.00
12/15/20215,600 shares $47,824.00 -35.6%0.1%0.8 $8.54
11/30/20218,700 shares $77,691.00 +13.0%0.2%1.5 $8.93
11/15/20217,700 shares $70,840.00 -10.5%0.1%1.2 $9.20
10/29/20218,600 shares $75,680.00 +24.6%0.2%1.1 $8.80
10/15/20216,900 shares $64,032.00 -33.7%0.1%0.9 $9.28
9/30/202110,400 shares $97,344.00 -3.7%0.2%0.8 $9.36
9/15/202110,800 shares $99,252.00 -12.9%0.2%0.8 $9.19
8/31/202112,400 shares $113,584.00 -29.1%0.2%0.9 $9.16
8/13/202117,500 shares $157,675.00 +7.4%0.3%1.4 $9.01
7/30/202116,300 shares $164,141.00 +109.0%0.3%1.1 $10.07
7/15/20217,800 shares $70,200.00 -25.7%0.1%0.5 $9.00
6/30/202110,500 shares $99,750.00 +15.4%0.2%0.8 $9.50
6/15/20219,100 shares $89,553.10 -37.7%0.2%0.7 $9.84
5/28/202114,600 shares $142,642.00 +31.5%0.3%1 $9.77
5/14/202111,100 shares $102,231.00 -11.9%0.2%0.6 $9.21
4/30/202112,600 shares $128,646.00 +46.5%0.2%0.5 $10.21
4/15/20218,600 shares $79,636.00 +28.4%N/A0 $9.26
3/31/20216,700 shares $62,645.00 +19.6%0.1%0.1 $9.35
3/15/20215,600 shares $60,312.00 -5.1%0.1%0.1 $10.77
2/26/20215,900 shares $62,776.00 -10.6%0.1%0.1 $10.64
2/12/20216,600 shares $74,382.00 -14.3%0.1%0.1 $11.27
1/29/20217,700 shares $57,365.00 +63.8%0.2%0.2 $7.45
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
1/15/20214,700 shares $29,586.50 +14.6%0.1%0.4 $6.30
12/31/20204,100 shares $24,559.00 -28.1%0.1%0.4 $5.99
12/15/20205,700 shares $36,423.00 +67.7%0.1%0.7 $6.39
11/30/20203,400 shares $20,400.00 -5.6%0.1%0.4 $6.00
11/15/20203,600 shares $20,700.00 +50.0%0.1%0.4 $5.75
10/30/20202,400 shares $12,504.00 -74.5%0.1%0.3 $5.21
10/15/20209,400 shares $52,828.00 -42.0%0.2%0.9 $5.62
9/30/202016,200 shares $87,966.00 -3.6%0.3%1.4 $5.43
9/15/202016,800 shares $88,032.00 +162.5%0.3%1 $5.24
8/31/20206,400 shares $33,408.00 -46.2%0.1%0.3 $5.22
8/14/202011,900 shares $66,878.00 -56.7%0.2%0.5 $5.62
7/31/202027,500 shares $136,950.00 +32.9%0.5%0.9 $4.98
7/15/202020,700 shares $125,235.00 +38.9%0.4%0.7 $6.05
6/30/202014,900 shares $71,669.00 +254.8%0.3%0.5 $4.81
6/15/20204,200 shares $17,808.00 +223.1%0.1%0.2 $4.24
5/29/20201,300 shares $5,824.00 -90.3%0.0%0 $4.48
5/15/202013,400 shares $54,404.00 -39.6%0.3%0.4 $4.06

ICCC Short Interest - Frequently Asked Questions

What is ImmuCell's current short interest?

Short interest is the volume of ImmuCell shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 4,500 shares of ICCC short. 0.08% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest.

What is a good short interest percentage for ImmuCell?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of ImmuCell's floating shares are currently sold short.

Is ImmuCell's short interest increasing or decreasing?

ImmuCell saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 4,500 shares, a decline of 65.9% from the previous total of 13,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ImmuCell's float size?

ImmuCell currently has issued a total of 8,983,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,790,000 shares.

How does ImmuCell's short interest compare to its competitors?

0.08% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmuCell: MediWound Ltd. (14.34%), Rezolute, Inc. (5.69%), Cardiff Oncology, Inc. (36.78%), Inventiva S.A. (1.13%), Fulcrum Therapeutics, Inc. (6.88%), biote Corp. (2.85%), SOPHiA GENETICS SA (0.09%), Gossamer Bio, Inc. (4.26%), Annexon, Inc. (9.29%), DBV Technologies S.A. (0.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short ImmuCell stock?

Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ImmuCell?

A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further.

How often is ImmuCell's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:ICCC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners